243 related articles for article (PubMed ID: 36335987)
21. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway.
Tao S; Chen Y; Hu M; Xu L; Fu CB; Hao XB
Mol Cell Biochem; 2022 Mar; 477(3):951-963. PubMed ID: 35098439
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA X-Inactive-Specific Transcript Promotes the Secretion of Inflammatory Cytokines in LPS Stimulated Astrocyte Cell Via Sponging miR-29c-3p and Regulating Nuclear Factor of Activated T cell 5 Expression.
Zhang M; Yang H; Chen Z; Hu X; Wu T; Liu W
Front Endocrinol (Lausanne); 2021; 12():573143. PubMed ID: 33776905
[TBL] [Abstract][Full Text] [Related]
23. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.
Wang Y; Xin D; Zhou L
Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644
[TBL] [Abstract][Full Text] [Related]
24. LncRNA XIST regulates myocardial infarction by targeting miR-130a-3p.
Zhou T; Qin G; Yang L; Xiang D; Li S
J Cell Physiol; 2019 Jun; 234(6):8659-8667. PubMed ID: 29226319
[TBL] [Abstract][Full Text] [Related]
25. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
Zhao CH; Bai XF; Hu XH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
[TBL] [Abstract][Full Text] [Related]
27. LncRNA XIST facilitates hypertrophy of ligamentum flavum by activating VEGFA-mediated autophagy through sponging miR-302b-3p.
Cao Y; Li J; Qiu S; Ni S; Duan Y
Biol Direct; 2023 May; 18(1):25. PubMed ID: 37226251
[TBL] [Abstract][Full Text] [Related]
28. lncRNA XIST/miR‑129‑2‑3p axis targets CCP110 to regulate the proliferation, invasion and migration of endometrial cancer cells.
Chen S; Liang Y; Shen Y; Wang X
Exp Ther Med; 2023 Apr; 25(4):159. PubMed ID: 36911384
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
30. Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis.
Li B; Lou G; Zhang J; Cao N; Yu X
BMC Cancer; 2022 Jan; 22(1):124. PubMed ID: 35100978
[TBL] [Abstract][Full Text] [Related]
31. LncRNA XIST promotes mitochondrial dysfunction of hepatocytes to aggravate hepatic fibrogenesis via miR-539-3p/ADAMTS5 axis.
Wu XJ; Xie Y; Gu XX; Zhu HY; Huang LX
Mol Cell Biochem; 2023 Feb; 478(2):291-303. PubMed ID: 35794289
[TBL] [Abstract][Full Text] [Related]
32. LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p.
Ma SQ; Wang YC; Li Y; Li XY; Yang J; Sheng YM
J Biol Regul Homeost Agents; 2020; 34(6):1993-2001. PubMed ID: 33191714
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
34. miR-375-3p contributes to hypoxia-induced apoptosis by targeting forkhead box P1 (FOXP1) and Bcl2 like protein 2 (Bcl2l2) in rat cardiomyocyte h9c2 cells.
Li Y; Li X; Wang L; Han N; Yin G
Biotechnol Lett; 2021 Feb; 43(2):353-367. PubMed ID: 33128129
[TBL] [Abstract][Full Text] [Related]
35. LncRNA XIST promotes extracellular matrix synthesis, proliferation and migration by targeting miR-29b-3p/COL1A1 in human skin fibroblasts after thermal injury.
Cao W; Feng Y
Biol Res; 2019 Sep; 52(1):52. PubMed ID: 31540582
[TBL] [Abstract][Full Text] [Related]
36. LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1/2 expression.
Liu L; Jiang H; Pan H; Zhu X
J Int Med Res; 2021 May; 49(5):3000605211016211. PubMed ID: 34018840
[TBL] [Abstract][Full Text] [Related]
37. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
[TBL] [Abstract][Full Text] [Related]
39. LncRNA XIST promotes myocardial infarction by regulating
Lin B; Xu J; Wang F; Wang J; Zhao H; Feng D
Aging (Albany NY); 2020 Apr; 12(8):7232-7247. PubMed ID: 32315985
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA SNHG12 facilitates the tumorigenesis of glioma through miR-101-3p/FOXP1 axis.
Sun Y; Liu J; Chu L; Yang W; Liu H; Li C; Yang J
Gene; 2018 Nov; 676():315-321. PubMed ID: 30098431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
